Clinical Trials Logo
  1. Home
  2. Cognition Disorders
  3. NCT02828813
  4. Details
NCT02828813 Clinical Trial

Neural Mechanisms of Motor and Cognitive Networks

Cognition Disorders Clinical Trial

Official title:
Neural Mechanisms of Motor and Cognitive Networks

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02828813
Other study ID # NRRA201607
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 2016
Est. completion date February 2019

Study information
Verified date March 2019
Source National Research Center for Rehabilitation Technical Aids
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study investigates the neural mechanisms of motor and cognitive networks using cognitive assessment, reaction time measurement, high-density EEG and fMRI.

Recruitment information / eligibility
Status Completed
Enrollment 120
Est. completion date February 2019
Est. primary completion date February 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Years to 80 Years
Eligibility Inclusion Criteria (for healthy people):

- right handed,

- no history of psychological/psychotic problems,

- no history of important diseases.

Exclusion Criteria (for healthy people):

- Being Pregnant or breast feeding

- having any non-MRI compatible conditions

Inclusion Criteria (for patients):

- right handed

- in a stable condition

- ability to follow complex commands

Exclusion Criteria (for patients):

- having any non-MRI compatible conditions

- inability to perform required tasks

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China National Research Center for Rehabilitation Technical Aids Beijing

Sponsors (1)
Lead Sponsor Collaborator
National Research Center for Rehabilitation Technical Aids

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Other reaction time measurement within one week
Other EEG within one week
Other fMRI within one week
Primary cognitive assessment scores within one week
See also
  Status Clinical Trial Phase
Completed NCT02488720 - Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Recruiting NCT03544801 - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting NCT02813434 - Cerebral Amyloid Imaging Using Florbetapir (AV-45) Phase 3
Completed NCT00400790 - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane N/A
Completed NCT00052091 - Therapy for Depressed Elders With Thought Problems Phase 3
Completed NCT00021866 - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy N/A
Completed NCT00267163 - Brain Imaging and Mental Disorders of Aging Intervention Phase 4
Not yet recruiting NCT04079075 - Multiple Interventions to Prevent Cognitive Decline N/A
Terminated NCT03696082 - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines N/A
Completed NCT02918539 - Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, not recruiting NCT01708837 - Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction Phase 4
Completed NCT01290939 - Bevacizumab and Lomustine for Recurrent GBM Phase 3
Terminated NCT00548327 - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype Phase 2
Unknown status NCT00256425 - Cognitive Rehabilitation of Glioma Patients Phase 3
Recruiting NCT03926351 - High Dose Omega 3 in People at Risk for Dementia Phase 2
Completed NCT02118571 - Schizophrenia Cognition Scale Development N/A
Completed NCT01481961 - Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease N/A
Completed NCT00788918 - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) N/A
Completed NCT00564902 - The Zeaxanthin and Visual Function Study N/A
Completed NCT00529581 - A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis Phase 2